Illumina Blasts Ariosa's $100M Counterclaim In Patent Suit
Genomics company Illumina Inc. accused rival Ariosa Diagnostics Inc. on Friday of violating California's anti-SLAPP law by bringing $100 million in counterclaims in Illumina's patent infringement suit, while Ariosa argued for...To view the full article, register now.
Already a subscriber? Click here to view full article